Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2003
05/01/2003US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
05/01/2003US20030083336 Dopamine D4 receptor ligands; treating psychosis, schizophrenia and affective disorders
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083329 Biologically active 4H-benzo [1,4] oxazin-3-ones
05/01/2003US20030083268 Isoquinoline compounds having antiinfective activity
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030080323 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2464290A1 Stents
05/01/2003CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
04/2003
04/30/2003CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin
04/30/2003CN1414964A Antibacterial heterobicyclic substituted phenyl oxazolidinones
04/30/2003CN1414961A Substituted oximes and hydrazones as neurokinin antagonists
04/30/2003CN1414953A Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and 5-hydroxytryptamine
04/30/2003CN1413990A Epimino substituted benzene derivative
04/30/2003CN1107059C Azole derivative
04/30/2003CN1107058C Subsitituted isoxazoles for treatment of inflammation
04/30/2003CN1107054C Method of preparation and separation of 2,4'-dipyridyl derivatives and its application
04/29/2003US6555570 Growth hormone secretagogous with improved bioavailability
04/29/2003US6555569 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
04/29/2003US6555565 Apoptosis inhibitor
04/29/2003US6555555 Fused thiophone derivatives and drugs containing the same as the active ingredient
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/29/2003US6555537 Piperazine derivatives and their use as anti-inflammatory agents
04/29/2003US6555536 Antiproliferative agents; antidiabetic agents
04/29/2003US6555501 4-trifluoromethyl-3-oxazolylpyridines, processes for their preparation, compositions comprising them and their use as pesticides
04/24/2003WO2003033493A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ
04/24/2003WO2003033486A1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
04/24/2003WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
04/24/2003WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
04/24/2003WO2003032993A1 Use of phosphorodiesterase iv inhibitors
04/24/2003WO2003032991A1 N-aroyl piperazine derivatives as orexin receptor antagonists
04/24/2003WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032981A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/24/2003WO2003032962A2 Dual action antibiotics
04/24/2003WO2003032731A1 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
04/24/2003WO2003016282A3 Substituted 1h-dihydropyrazoles, their preparation and use
04/24/2003WO2002102376A8 ORALLY DELIVERABLE PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE COMPOUND HAVING AN AMINOSULFONYL GROUP (cox-2 INHIBITOR), A POLYETHYLENE GLYCOL AND A FREE-RADICAL SCAVENGING ANTIOXIDANT
04/24/2003WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
04/24/2003WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase
04/24/2003US20030078432 Novel benzotriazoles anti-inflammatory compounds
04/24/2003US20030078426 Thiazolidine or oxazolidine compounds useful for preventing or therapeutical agents for various diseases such as diabetes and hyperlipemia
04/24/2003US20030078419 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection
04/24/2003US20030078282 For therapy of allergic dermatitis and atopy in animals and humans
04/24/2003US20030078279 For therapy and prophylaxis of pain, central nervous system disorder or the like in mammalian subjects
04/24/2003US20030078278 Spiropiperidine compounds as ligands for ORL-1 receptor
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078274 Method of reducing neuronal injury or apoptosis
04/24/2003US20030078271 Pyrimidine and indolone derivatives
04/24/2003US20030078265 Inhibitors of nitric oxide synthase (nos)
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030078260 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
04/24/2003US20030078259 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders
04/24/2003US20030078258 Adrenergic blocking agents
04/24/2003US20030078251 Triglyceride and cholesterol lowering activity and treats hyperlipidemia
04/24/2003US20030078249 VLA-4 inhibitor compounds
04/24/2003US20030078166 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030077635 Dendrimer for use as diagnostic tools in chemical analysis
04/24/2003CA2463469A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/23/2003EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
04/23/2003EP1303511A1 Oxazolidinone derivatives as antimicrobials
04/23/2003EP1303510A2 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/23/2003EP1303509A1 Beta3 adrenergic agonists
04/23/2003EP1303506A1 6-heteroarylphenanthridines
04/23/2003EP1303500A1 Heterocyclic fluoroalkenyl thioethers (ii)
04/23/2003EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors
04/23/2003EP1303496A1 Pyrimidine derivatives
04/23/2003EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
04/23/2003EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors
04/23/2003EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/23/2003EP1140925B1 (3,4 dihydro-2h-benzo[1,4] oxazinyl-methyl)- 3-(1h-indol-3- yl)-alkyl -amines
04/23/2003EP1133483B1 Il-5 inhibiting 6-azauracil derivatives
04/23/2003EP1114046B1 Interleukin-5 inhibiting 6-azauracil derivatives
04/23/2003EP1086179B1 Energy transfer assay method and reagent
04/23/2003EP1077975B1 Water soluble azoles as broad-spectrum antifungals
04/23/2003EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
04/23/2003EP0906311B1 N-sulfonylimidazoles used as fungicides
04/23/2003EP0844998B1 Halobenzimidazoles and their use as microbicides
04/23/2003EP0787725B1 Quinoline derivative
04/23/2003CN1413216A Azolyalkyl-oxa (di) azolyl pyri (mi) dine derivatives, method for their production and use as pesticides
04/23/2003CN1413211A Substituted 1,3,4-oxadiazoles and method of producing TNF-alpha levels
04/23/2003CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/23/2003CN1413209A 3-(4.5-dihydroisoxazole-5-yl)-benzoylpyrazole
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413205A 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1106390C Tachykinin receptor antagonist substituted methyl keto-morpholine crystal form
04/23/2003CN1106384C Indoline-2-one derivatives, its preparing method and its medicinal compositions
04/23/2003CN1106195C Use of thazolinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552058 Oxazolidinedione derivatives and their use
04/22/2003US6552057 Serotonin 5-HT3 receptor partial activator
04/22/2003US6552054 Chromone derivatives, process for the preparation of the same and uses thereof
04/22/2003US6552042 Anticoagulants
1 ... 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 ... 647